Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson’s Drug But Q1 Earnings Are Mixed

All NewsMay 2, 2025

Amneal Pharmaceuticals reported first-quarter 2025 adjusted earnings per share of 21 cents, up from 14 cents a year ago.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson’s Drug But Q1 Earnings Are Mixed

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Disney World closes popular ride after major change

Walmart has an electric fireplace TV stand with an ‘upscale, cozy vibe’ for 47% off

Denny’s restaurants operator files for Chapter 11 bankruptcy

Nasdaq tumbles nearly 4% as chip rout intensifies in wake of midterms

Marco Rubio ‘on resignation watch’ – report